Bimekizumab Provides Rapid and Sustained Improvements in Quality of Life That Correlate With Clinical Outcomes in Patients With Moderate to Severe Plaque Psoriasis: 60 Week Results from a Randomized , Double Blinded , Phase 2b Extension Study. J of Skin 2019, 3, S35. https://doi.org/10.25251/skin.3.supp.35.